GlassScriptPhysician profile
Vishal Gupta
NPI 1114162625
$1,950.35
in general payments reported to CMS, 2019-2025
12 companies · $295 in 2025
The $295 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.18 · 2021: $473 · 2022: $489 · 2023: $519 · 2024: $101 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $675.00 | 2021-2023 | Xarelto |
| Abbvie INC. | $479.29 | 2021-2025 | |
| Shockwave Medical, INC | $296.64 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $178.07 | 2022-2024 | Zeposia, Camzyos |
| Cordis US Corp. | $79.30 | 2023 | Mynxgrip |
| Boston Scientific Corporation | $72.18 | 2019 | |
| Medtronic, INC. | $70.00 | 2022 | |
| Genzyme Corporation | $38.71 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $32.12 | 2025 | Dupixent |
| Olympus America INC. | $16.82 | 2024 | Single Use Electrosurgical Snare Sd-400 |
| Cardiva Medical, INC. | $12.22 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.